Back to Journals » Drug Design, Development and Therapy » Volume 13

RETRACTED ARTICLE: TMF inhibits miR-29a/Wnt/β-catenin signaling through upregulating Foxo3a activity in osteoarthritis chondrocytes

Authors Huang X, Chen Z, Shi W, Zhang R, Li L , Liu H , Wu L 

Received 22 March 2019

Accepted for publication 24 May 2019

Published 19 June 2019 Volume 2019:13 Pages 2009—2019

DOI https://doi.org/10.2147/DDDT.S209694

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Jianbo Sun



This paper has been retracted.

Huang X, Chen Z, Shi W, et al. Drug Des Devel Ther.2019;13:2009–2019.

The Editor and Publisher of Drug Design, Development and Therapy are retracting the published article. An investigation raised concerns regarding the duplication of western blot bands in Figure 5B, where the images for Figure 5B IP: IgG; IB: Foxo3a and IP: IgG; IB: TCF4 are duplicated.

The authors cooperated with the investigation and provided data associated with the reported study. However, despite the authors’ assistance, a satisfactory explanation for how the images came to be duplicated could not be provided, and the validity of the published work could not be verified. The decision was made to retract the article and the authors were notified of this.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Creative Commons License © 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.